Various other embodiments include a method of treating a form of {HEAD ~ cancer} characterized by a high level of PTTG1 relative to a normal non cancerous subject, comprising administering a therapeutically effective amount of {TAIL ~ a PTTG1 inhibitor}, and administering a composition comprising a senescence inducing agent 
Various other embodiments include a method of treating a form of { HEAD ~ cancer } characterized by a high level of PTTG1 relative to a normal non cancerous subject , comprising administering a therapeutically effective amount of { TAIL ~ a PTTG1 inhibitor } , and administering a composition comprising a senescence inducing agent
OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH HEAD HEAD HEAD HEAD HEAD OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH TAIL TAIL TAIL TAIL TAIL TAIL TAIL OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH